|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
����,ϸ������ |
|
������ |
| ��������������� | |
|
Ҧ�� |
|
��־ǿ |
|
������ |
| PubMed | |
|
Article by |
|
Article by |
|
Article by |
TH2��ϸ�����������о���չ
Ҧ��, ��־ǿ, ������
�й�ҽѧ��ѧԺ���й�Э��ҽ�ƴ�ѧƤ�����о���, �Ͼ�210042
TH2��ϸ�����������������-4R������-6R�Ͱ���-10R.��༲������ϸ�����Ӽ���������쳣,�ֱ�����еĹ���TH2��ϸ����������ļ����о��ȵ���һ��������ʾ���ڼ��������е�����,�������ٴ����з���ҩ�Լ����ṩ�µ������ֶΡ�
[2] Kruse S, Forster J, Kuehr J, et al. Characterization of the membrane-bound and a soluble form of human IL-4 receptor alpha produced by alternative splicing. Int Immunol, 1999, 11 (12):1965-1970.
[3] Jones SA, Horiuchi S, Topley N, et al. The soluble interleukin 6 receptor:mechanisms of production and implications in disease. FASEB J, 2001, 15(1):43-58.
[4] Moore KW, de Waal Malefyt R, Coffman RL, et al. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol, 2001, 19:683.
[5] Schnyder B, Lugli S, Feng N,et al. Interleukin-4 (IL-4) and IL 13 bind to a shared heterndimeric complex on endothelial cells mediating vascular cell adhesion molecule-1 induction in the absence of the common gamma chain. Blood, 1996, 87(10):4286-4295.
[6] Hatanaka H, Abe Y, Kamiya T, et al. Clinical implications of inter leukin (IL)-10 induced by non-small-cell lung cancer. Ann Oncol, 2000, 11(7):815-819.
[7] Taniyama T, Takai S, Miyazaki E, et al. The human interleukin-10receptor gene maps to chromosome 11q23.3. Hum Genet, 1995, 95(1):99-101.
[8] Taha RA, Leung DY, Ghaffar O, et al. In vivo expression of cytokine receptor mRNA in atopic dermatitis. J Allergy Clin Immunol, 1998, 102(2):245-250.
[9] Dubois GR, Schweizer RC, Versluis C, et al. Human eosinophils con stitutively express a functional interleukin-4 receptor:interleukin-4-induced priming of chemotactic responses and induction of PI-3 ki nase activity. Am J Respir Cell Mol Biol, 1998, 19(4):691-699.
[10] Nakashima H, Akahoshi M, Tanaka Y, et al. Polymorphisms withinthe interleukin-10 receptor eDNA gene (IL10R) in Japanese pa tients with systemic lupus erythematosus. Rheumatology (Oxford), 1999, 38(11):1142-1144.
[11] Furusu A, Miyazaki M, Koji T, et al. Involvement of IL-4 in human glomerulonephritis:an in situ hybridization study of IL-4 mRNA andIL-4 receptor mRNA. J Am Soc Nephrol, 1997, 8(5):730-741.
[12] Rivas D, Mozo L, Zamorano J, et al. Upregulated expression of IL 4 receptors and increased levels of IL-4 in rheumatoid arthritis patients. J Autoimmun, 1995, 8(4):587-600.
[13] Parry RG, Gillespie KM, Mathieson PW. Effects of type 2 cytokines on glomerular epithelial cells. Exp Nephrol, 2001,9(4):275-283.
[14] Kawakami K, Leland P, Puri RK. Structure, function, and targetingof interleukin 4 receptors on human head and neck cancer cells. Cancer Res, 2000, 60(11):2981-2987.
[15] Joshi BH, Leland P, Asher A, et al. In situ expression of interleukin-4 (IL-4) receptors in human brain tumors and cvtotoxicitv of a recombinant IL-4 cytotoxin in primary glioblastoma cell cultures. Cancer Res, 2001, 61 (22):8058-8061.
[16] Obiri NI, Siegel JP, Varricchio F, et al. Expression of high-affinity IL-4 receptors on human melanoma, ovarian and breast carcinoma cells. Clin Exp Immunol, 1994, 95 (1):148-155.
[17] Labm H, Schnyder B, Wyniger J, et al. Growth inhibition of human eolorectal-carcinoma cells by interleukin-4 and expression of functional interleukin-4 receptors. Int J Cancer, 1994, 59 (3):440-447.
[18] Kotsimbos TC, Ghaffar O, Minshall EM, et al. Expression of the IL 4 receptor alpha-subunit is increased in bronchial biopsy specimens from atopic and nonatopic asthmatic subjects. J Allergy Clin Immunol, 1998, 102(5):859-866.
[19] Udagawa N, Takahashi N, Katagiri T,et al. Interleukin (IL)-6 in duction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors. J Exp Med, 1995, 182(5):1461-1468.
[20] Nishimoto N, Kishimoto T, Yoshizaki K. Anti-interleukin 6 receptor antibody treatment in rheumatic disease. Ann Rheum Dis, 2000, 59 (Suppl 1):i21-i27.
[21] Marz P, Gadient RA, Otten U. Expression of interleukin-6 receptor (IL-6R) and gpl30 mRNA in PC12 cells and sympathetic neurons:modulation by tumor necrosis factor alpha (TNF-alpha). Brain Res, 1996, 706(1):71-79.
[22] Szczepek AJ, Belch AR, Pilarski LM. Expression of IL-6 and IL 6 receptors by circulating clonotypic B cells in multiple myeloma:potential for autocrine and paracrine networks. Exp Hematol, 2001, 29 (9):1076-1081.
[23] Diamant M, Hansen MB, Rieneck K, et al. Differential interleukin 6 (IL-6) responses of three established myeloma cell lines in the presence of soluble human IL-6 receptors. Leuk Res, 1996, 20 (4):291-301.
[24] Avdiushko R, Hongo D, Lake-Bullock H,et al. IL-10 receptor dys function in macrophages during chronic inflammation. J Leukoc Biol, 2001,70(4):624-632.
[25] Jurlander J, Lai CF, Tan J, et al. Characterization of interleukin-10 receptor expression on B-cell chronic lymphocytic leukemia cells. Blood, 1997, 89(11):4146-4152.
[26] Iannone F, De Bari C, Dell Accio F, et al. Interleukin-10 and inter leukin-10 receptor in human osteoarthritic and healthy chondrocytes.Clin Exp Rheumatol, 2001, 19(2):139-145.